期刊文献+

常规放疗对比加速超分割放疗治疗老年中晚期非小细胞肺癌的疗效 被引量:1

下载PDF
导出
摘要 目的 探究常规放疗对比加速超分割放疗治疗老年中晚期非小细胞肺癌的疗效.方法 研究对象为我院2017.2-2018.2收治的80例老年中晚期非小细胞肺癌患者,将其采用随机数字表法分成放疗1组与放疗2组,40例放疗1组采用加速超分割放疗治疗,另40例放疗2组采用常规放疗.探讨实施不同放疗对治疗效果、放疗毒性反应发生率及短期生存率的影响.结果 放疗1组总有效率(85.00%)显著比放疗2组(57.50%)高(P<0.05),在骨髓抑制、放射形食管炎、放射形肺炎、放射性口腔溃疡等放疗毒性反应发生率上,放疗1组(85.00%、82.50%、87.50%、87.50%)与放疗2组(87.50%、85.00%、85.00%、90.00%)无显著差异(P>0.05),而在1年内生存率上,放疗1组(82.50%)相比放疗2组(57.50%)显著较高(P<0.05).结论 加速超分割放疗能避免放疗过程中肿瘤再增殖情况,提升疗效,不会增加不良反应率,提升患者短期生存率,此方法值得应用与推广.
作者 牛广宇
出处 《医学信息》 2018年第A02期308-309,共2页 Journal of Medical Information
  • 相关文献

参考文献2

二级参考文献20

  • 1AndrewsDW ScottCB SperdutoPW FlandersAE GasparLE SchellMC Werner-WasikM DemasW RyuJ BaharyJP SouhamiL RotmanM MehtaMP CurranWJJr.Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase Ⅲ resuIts of the RTOG 9508 randomised trial[J].中国神经肿瘤杂志,2004,2(3):192-192. 被引量:212
  • 2王燕,王颖,王彬,王子平,张湘茹,储大同,孙燕.吉非替尼治疗非小细胞肺癌脑转移的初步结果[J].中国肺癌杂志,2006,9(5):447-451. 被引量:33
  • 3Komatsu T, Kunieda E,Oizumi Y,et al. Clinical characteristics ofbrain metastases from lung cancer according to histological type:Pretreatment evaluation and survival following whole-brain ra-diotherapy [J]. Mol Clin Oncol,2013,1(4) :692-698.
  • 4Tsao MN, Lloyd N, Wong RKS, et al. Whole brain radiotherapyfor the treatment of newly diagnosed multiple brain metastases[J]. Cochrane Database Syst Rev,2012,4 :CD003869.
  • 5Patil CG, Pricola K,Sarmiento JM, et al. Whole brain radiationtherapy (WBRT) alone versus WBRT and radiosurgery for thetreatment of brain metastases [J]. Cochrane Database Syst Rev(Online),2012,9:CD006121.
  • 6Zhuang HQ, Yuan ZY, Wang J, et al. Phase H study of wholebrain radiotherapy with or without erlotinib in patients with mul-tiple brain metastases from lung adenocarcinoma [J]. Drug DesDevel Ther,2013,7:1179-1186.
  • 7Welsh JW, Komaki R, Amini A, et al. Phase H trial of erlotinibplus concurrent whole-brain radiation therapy for patients withbrain metastases from non-small-cell lung cancer [J], J Clin On-col,2013,31(7) :895-902.
  • 8Pesce GA,Klingbiel D’Ribi K,et al. Outcome, quality of life andcognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy com-bined with gefitinib or temozolomide. A randomised phase II tri-al of the Swiss Group for Clinical Cancer Research (SAKK 70/03)[J]. Eur J Cancer,2012,48(3) :377-384.
  • 9Sperduto PW, Wang M,Robins HI,et al. A phase 3 trial of wholebrain radiation therapy and stereotactic radiosurgery alone versusWBRT and SRS with temozolomide or erlotinib for non-small celllung cancer and 1 to 3 brain metastases : Radiation Therapy On-cology Group 0320 [J]. Int J Radiat Oncol Biol Phys, 2013 , 85.5):1312-1318.
  • 10Cai Y, Wang JY, Liu H. Clinical observation of whole brain ra-diotherapy concomitant with targeted therapy for brain metasta-sis in non-small cell lung cancer patients with chemotherapy fail-ure [J]. Asian Pac J Cancer Prev,2013 ,14(10) : 5699-5703.

共引文献51

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部